Vedere Bio II Presents Positive New Data Supporting Its Proprietary Platform at the 25th Annual ASGCT Meeting
/PRNewswire/ -- Vedere Bio II, Inc., a company developing transformative, next-generation therapies for vision restoration and preservation, today will present...
United Kingdom United States Gabor Veres Prnewswire Vedere Bio Ii Inc Development Or Manufacturing Meeting Of The American Society Gene
Source: prnewswire.com